Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193) - Sledge,G.W.; Neuberg,D.; Bernardo,P. (J Clin Oncol, 2003)